Table 3 Characteristics of patients included in the CINV analysis.
Characteristic | All patients (n = 36) |
|---|---|
Median age, years (IQR) | 59 (52–65) |
Sex, male | 20 (56, 40–70) |
Performance status | |
0 | 33 (92, 78–97) |
1 | 2 (6, 2–18) |
2 | 1 (3, 0.5–14) |
Chemotherapy regimen | |
FOLFOX | 10 (28, 16–44) |
CAPOX | 26 (72, 56–84) |
Use of molecular target drug | |
Yes | 12 (33, 20–50) |
Colorectal resection | |
Yes | 30 (83, 68–92) |
Stoma | |
Ileostomy | 4 (11, 4–25) |
Colostomy | 3 (8, 3–22) |
Purpose of chemotherapy | |
Neoadjuvant treatment | 2 (6, 2–18) |
Adjuvant treatment | 18 (50, 34–66) |
Metastatic disease | 16 (44, 30–60) |
Smoking history | |
Never | 17 (47, 32–63) |
Ex-smoker | 19 (53, 37–68) |
Alcohol use | |
Light/non-drinker | 28 (78, 62–88) |
Drinker | 8 (22, 12–38) |
History of vomiting during pregnancy | 8 (50, 28–72) |
History of motion sickness | 5 (14, 6–29) |
